Srinivas Vourganti, MD
@vourganti.bsky.social
Urologist & cancer surgeon @RushMedical in Chicago (formerly at the NIH/NCI). Striving for safer, more effective, and personalized cancer care for all... #GoBlue
Many say focal therapy is "experimental" and ask "where is the data?" A few of us got together and performed a trial in the USA to address these concerns. Join us for a zoom this Fri Feb 13th to see how it turned out (Hint: pretty great) us02web.zoom.us/webinar/regi...
Welcome! You are invited to join a webinar: The NanoKnife System for Prostate Tumors: PRESERVE Outcomes and Real-World Case Selecting Presented by the Focal Therapy Society. After registering, you wil...
Join us for a focused update on the evolving role of Irreversible Electroporation (IRE) NanoKnife in focal prostate cancer. Drs. Tom Polascik and Michael Rothberg will review current evidence, techniq...
us02web.zoom.us
February 12, 2026 at 6:53 AM
Many say focal therapy is "experimental" and ask "where is the data?" A few of us got together and performed a trial in the USA to address these concerns. Join us for a zoom this Fri Feb 13th to see how it turned out (Hint: pretty great) us02web.zoom.us/webinar/regi...
My how we've grown! Our annual Rush University Urology program robotics boot camp now requires three separate ORs, for multiport XI, multiport DV5, and SP single port to cover it all. Thanks to @intuitivesurg.bsky.social for the support. Never stop building for our patients, residents and students!
October 9, 2025 at 2:25 AM
My how we've grown! Our annual Rush University Urology program robotics boot camp now requires three separate ORs, for multiport XI, multiport DV5, and SP single port to cover it all. Thanks to @intuitivesurg.bsky.social for the support. Never stop building for our patients, residents and students!
